Literature DB >> 12846385

Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders.

Cynthia A Molloy1, Patricia Manning-Courtney.   

Abstract

The purpose of this study was to estimate the prevalence of chronic gastrointestinal symptoms in a general population of children with autism or autistic spectrum disorder (ASD). The study site was a clinic specializing in ASD in a large pediatric medical center serving a 10 county area in the midwestern USA. In a sample of 137 children, age 24-96 months, classified as having autism or ASD by the Autism Diagnostic Observation Schedule-Generic, 24 percent had a history of at least one chronic gastrointestinal symptom. The most common symptom was diarrhea, which occurred in 17 percent. There was no association between chronic gastrointestinal symptoms and a history of developmental regression. The potential phenotypic association between autism and gastrointestinal symptoms is discussed.

Entities:  

Mesh:

Year:  2003        PMID: 12846385     DOI: 10.1177/1362361303007002004

Source DB:  PubMed          Journal:  Autism        ISSN: 1362-3613


  71 in total

1.  Physician Perspectives on Providing Primary Medical Care to Adults with Autism Spectrum Disorders (ASD).

Authors:  Marji Erickson Warfield; Morgan K Crossman; Jennifer Delahaye; Emma Der Weerd; Karen A Kuhlthau
Journal:  J Autism Dev Disord       Date:  2015-07

2.  Is there a 'regressive phenotype' of Autism Spectrum Disorder associated with the measles-mumps-rubella vaccine? A CPEA Study.

Authors:  Jennifer Richler; Rhiannon Luyster; Susan Risi; Wan-Ling Hsu; Geraldine Dawson; Raphael Bernier; Michelle Dunn; Susan Hepburn; Susan L Hyman; William M McMahon; Julie Goudie-Nice; Nancy Minshew; Sally Rogers; Marian Sigman; M Anne Spence; Wendy A Goldberg; Helen Tager-Flusberg; Fred R Volkmar; Catherine Lord
Journal:  J Autism Dev Disord       Date:  2006-04

3.  Challenging behaviours at early adulthood in autism spectrum disorders: topography, risk factors and evolution.

Authors:  C Rattaz; C Michelon; K Munir; A Baghdadli
Journal:  J Intellect Disabil Res       Date:  2018-05-24

4.  Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder.

Authors:  Logan K Wink; Ernest V Pedapati; Ryan Adams; Craig A Erickson; Kahsi A Pedersen; Eric M Morrow; Desmond Kaplan; Matthew Siegel
Journal:  J Autism Dev Disord       Date:  2018-11

5.  Behavioral Phenotype of ASD Preschoolers with Gastrointestinal Symptoms or Food Selectivity.

Authors:  Margherita Prosperi; Elisa Santocchi; Giulia Balboni; Antonio Narzisi; Margherita Bozza; Francesca Fulceri; Fabio Apicella; Roberta Igliozzi; Angela Cosenza; Raffaella Tancredi; Sara Calderoni; Filippo Muratori
Journal:  J Autism Dev Disord       Date:  2017-11

6.  Slower cortisol response during ACTH stimulation test in autistic children.

Authors:  Jasna Marinović-Curin; Ivana Marinović-Terzić; Zorana Bujas-Petković; Ljubinka Zekan; Veselin Skrabić; Zoran Dogas; Janos Terzić
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

7.  Reduced bone cortical thickness in boys with autism or autism spectrum disorder.

Authors:  Mary L Hediger; Lucinda J England; Cynthia A Molloy; Kai F Yu; Patricia Manning-Courtney; James L Mills
Journal:  J Autism Dev Disord       Date:  2008-05

8.  A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder.

Authors:  Benjamin L Handen; Raun D Melmed; Robin L Hansen; Michael G Aman; David L Burnham; Jon B Bruss; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2009-01-16

9.  Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism.

Authors:  S Jill James; Stepan Melnyk; George Fuchs; Tyra Reid; Stefanie Jernigan; Oleksandra Pavliv; Amanda Hubanks; David W Gaylor
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

10.  The serotonergic system: its role in pathogenesis and early developmental treatment of autism.

Authors:  D I Zafeiriou; A Ververi; E Vargiami
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.